Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
COVID-19 News New study finds strong immune response following COVID-19 vaccination A new study carried out in collaboration with the University of Birmingham with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine.
COVID-19 New gene therapy innovation centre to advance scientific discoveries into life-changing treatments
Posted 11 May 2021 Agents that target viral RNA could be the basis for next generation broad spectrum anti-viral drugs– new study A new approach to tackling viruses by targeting the 'control centre' in viral RNA could lead to broad spectrum anti-viral drugs and provide a first line of defence against future pandemics, according to new research.
Posted 06 May 2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb The University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.
Posted 05 May 2021 Successful virtual conference for global bacterial vaccinology network More than 200 scientists, industry figures and policy-makers from across the world gathered online for the BactiVac Virtual Network Conference 2021 hosted at the University of Birmingham.
Posted 21 April 2021 Birmingham Health Innovation Campus takes another step forward after planning permission granted Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.
Posted 14 April 2021 Over-80s show similar antibody responses following single vaccination with either Pfizer or AstraZeneca vaccine – but cellular responses are enhanced after AstraZeneca vaccine People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination, research led by the University of Birmingham establishes.
Posted 01 April 2021 Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people A University of Birmingham-led study has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response.